All terms in EFO
| Label | Id | Description |
|---|---|---|
| obsolete_Bangstad syndrome | Orphanet_1227 | |
| obsolete_Banki syndrome | Orphanet_1228 | |
| obsolete_Baller-Gerold syndrome | Orphanet_1225 | |
| obsolete_Bamforth-Lazarus syndrome | Orphanet_1226 | [Bamforth-Lazarus syndrome is a very rare syndrome of congenital hypothyroidism characterized by thyroid dysgenesis (in most cases athyreosis), cleft palate and spiky hair, with or without choanal atresia, and bifid epiglottis. Facial dysmorphism and porencephaly have been reported in isolated cases.] |
| erythronate | CHEBI_133792 | [A hydroxy monocarboxylic acid anion obtained by deprotonation of the carboxy group of any erythronic acid; major species at pH 7.3.] |
| Cronobacter turicensis | NCBITaxon_413502 | |
| Cronobacter muytjensii | NCBITaxon_413501 | |
| obsolete_qualitative or quantitative defects of dystrophin | Orphanet_207085 | |
| obsolete_glomuvenous malformation | Orphanet_83454 | |
| Salmonella enterica subsp. enterica serovar Senftenberg | NCBITaxon_28150 | |
| urinary nitrogen measurement | EFO_0005190 | |
| obsolete_qualitative or quantitative defects of integrin alpha-7 | Orphanet_207098 | |
| serum IgG glycosylation measurement | EFO_0005193 | [quantification of N-linked IgG glycans in a serum sample] |
| amyloid-beta measurement | EFO_0005194 | [quantification of the amyloid-beta, either in a sample of cerebro-spinal fluid or via PET scan, used as a biomarker for Alzheimer's disease] |
| obsolete_qualitative or quantitative defects of merosin | Orphanet_207094 | |
| waist height ratio | EFO_0005191 | [A quantification of the waist-height WHtR - a measurement of body fat distribution. ] |
| red blood cell distribution width | EFO_0005192 | [measure of the variation of red blood cell (RBC) volume] |
| beta-2 microglobulin measurement | EFO_0005197 | [A quantification of the MHC component beta-2 microglobulin, typically in a blood sample. Used as progostic indicator in multiple myeloma, and diseases associated with increased cell turnover. Levels are also elevated in several benign conditions such as chronic inflammation, liver disease, renal dysfunction, some acute viral infections, and a number of malignancies, especially hematologic malignancies associated with the B-lymphocyte lineage.] |
| transplant outcome measurement | EFO_0005198 | |
| response to cholinesterase inhibitor | EFO_0005195 | [Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a cholinesterase inhbitor stimulus.] |